DNA demethylation and carcinogenesis

N P Kisseljova1, F L Kisseljov

  • 1Institute of Carcinogenesis, Blokhin Russian Cancer Research Center, Moscow, 115478, Russia. natalia_kis@crc.umos.ru

Biochemistry. Biokhimiia
|August 16, 2005
PubMed

Insights

Global DNA demethylation in cancer cells promotes tumor growth and spread. Understanding these DNA methylation changes is crucial for developing new anti-tumor therapies.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genetics

Background:

  • DNA methylation is vital for gene expression regulation.
  • Cancer cells exhibit paradoxical DNA methylation: global hypomethylation and local hypermethylation.
  • While hypermethylation of tumor suppressors is known, the role of global demethylation in cancer is less understood.

Purpose of the Study:

  • To review recent findings on the role of global DNA demethylation in carcinogenesis.
  • To discuss the independent nature of DNA hypo- and hypermethylation in tumor cells.
  • To highlight the therapeutic implications of understanding DNA methylation dynamics in cancer.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of studies investigating DNA methylation patterns in tumor cells.
  • Discussion of gene expression alterations linked to DNA methylation changes.

Main Results:

  • Global DNA hypomethylation in tumors is linked to hypomethylation of repetitive sequences and increased genetic instability.
  • Hypomethylation and activation of specific genes can enhance tumor growth, invasion, and metastasis.
  • DNA hypo- and hypermethylation processes operate independently and affect different genes involved in malignant transformation.

Conclusions:

  • Global DNA demethylation plays a significant role in cancer progression, distinct from tumor suppressor gene hypermethylation.
  • Understanding the interplay between DNA hypomethylation and hypermethylation is critical for novel anti-cancer strategies.
  • The reversibility of DNA methylation offers potential for therapeutic interventions targeting cancer epigenetics.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...